Nicholas Company’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.71M | Buy |
85,735
+135
| +0.2% | +$10.9K | 0.12% | 140 |
|
|
2026
Q1 | $7.42M | Buy |
85,600
+14,785
| +21% | +$1.42M | 0.15% | 125 |
|
|
2025
Q4 | $6.8M | Buy |
70,815
+19,740
| +39% | +$1.92M | 0.12% | 152 |
|
|
2025
Q3 | $4.86M | Sell |
51,075
-17,550
| -26% | -$1.61M | 0.08% | 191 |
|
|
2025
Q2 | $5.98M | Sell |
68,625
-34,810
| -34% | -$2.95M | 0.1% | 175 |
|
|
2025
Q1 | $9.29M | Sell |
103,435
-30
| -0% | -$2.68K | 0.16% | 124 |
|
|
2024
Q4 | $8.26M | Sell |
103,465
-25
| -0% | -$2.16K | 0.13% | 142 |
|
|
2024
Q3 | $9.32M | Sell |
103,490
-5,850
| -5% | -$492K | 0.15% | 133 |
|
|
2024
Q2 | $8.61M | Hold |
109,340
| – | – | 0.14% | 129 |
|
|
2024
Q1 | $9.53M | Hold |
109,340
| – | – | 0.16% | 119 |
|
|
2023
Q4 | $9.01M | Sell |
109,340
-30
| -0% | -$2.29K | 0.16% | 119 |
|
|
2023
Q3 | $8.57M | Sell |
109,370
-507,095
| -82% | -$42.5M | 0.17% | 118 |
|
|
2023
Q2 | $54.3M | Hold |
616,465
| – | – | 1.04% | 33 |
|
|
2023
Q1 | $49.7M | Hold |
616,465
| – | – | 1.01% | 37 |
|
|
2022
Q4 | $47.9M | Hold |
616,465
| – | – | 1.02% | 31 |
|
|
2022
Q3 | $49.8M | Buy |
616,465
+50
| +0% | +$4.49K | 1.14% | 23 |
|
|
2022
Q2 | $55.3M | Sell |
616,415
-240
| -0% | -$24.3K | 1.21% | 19 |
|
|
2022
Q1 | $68.4M | Sell |
616,655
-3,000
| -0.5% | -$317K | 1.22% | 18 |
|
|
2021
Q4 | $64.1M | Buy |
619,655
+59,710
| +11% | +$6.91M | 1.04% | 28 |
|
|
2021
Q3 | $70.2M | Buy |
559,945
+125
| +0% | +$16.2K | 1.24% | 13 |
|
|
2021
Q2 | $69.5M | Hold |
559,820
| – | – | 1.22% | 10 |
|
|
2021
Q1 | $66.1M | Sell |
559,820
-1,000
| -0.2% | -$117K | 1.24% | 13 |
|
|
2020
Q4 | $65.7M | Sell |
560,820
-800
| -0.1% | -$88.1K | 1.24% | 15 |
|
|
2020
Q3 | $58.4M | Buy |
561,620
+9,830
| +2% | +$987K | 1.23% | 18 |
|
|
2020
Q2 | $50.6M | Buy |
551,790
+17,825
| +3% | +$1.71M | 1.16% | 22 |
|
|
2020
Q1 | $48.2M | Buy |
533,965
+2,540
| +0.5% | +$270K | 1.36% | 14 |
|
|
2019
Q4 | $60.3M | Sell |
531,425
-13,100
| -2% | -$1.44M | 1.27% | 17 |
|
|
2019
Q3 | $59.1M | Sell |
544,525
-5,000
| -0.9% | -$522K | 1.33% | 18 |
|
|
2019
Q2 | $53.5M | Sell |
549,525
-45
| -0% | -$4.11K | 1.19% | 22 |
|
|
2019
Q1 | $50.1M | Sell |
549,570
-4,850
| -0.9% | -$434K | 1.19% | 22 |
|
|
2018
Q4 | $50.4M | Hold |
554,420
| – | – | 1.31% | 19 |
|
|
2018
Q3 | $54.5M | Hold |
554,420
| – | – | 1.19% | 23 |
|
|
2018
Q2 | $47.5M | Sell |
554,420
-22,370
| -4% | -$1.87M | 1.11% | 27 |
|
|
2018
Q1 | $46.3M | Sell |
576,790
-178,400
| -24% | -$14.7M | 1.05% | 33 |
|
|
2017
Q4 | $61M | Sell |
755,190
-3,100
| -0.4% | -$248K | 1.33% | 21 |
|
|
2017
Q3 | $59M | Buy |
758,290
+16,735
| +2% | +$1.39M | 1.31% | 23 |
|
|
2017
Q2 | $65.8M | Buy |
741,555
+100
| +0% | +$8.43K | 1.46% | 17 |
|
|
2017
Q1 | $59.7M | Buy |
741,455
+100,700
| +16% | +$7.87M | 1.36% | 24 |
|
|
2016
Q4 | $45.6M | Sell |
640,755
-1,765
| -0.3% | -$139K | 1.02% | 37 |
|
|
2016
Q3 | $55.5M | Buy |
+642,520
| New | +$56M | 1.22% | 30 |
|
Other funds holding MDT
Nicholas Company's MDT Position: Q2 2026 in Review
Nicholas Company increased its Medtronic (MDT) stake by 0.16% in Q2 2026, buying an estimated $10.9K and bringing the position to 85,735 shares worth $6.71M. The position accounts for 0.12% of the portfolio, ranked #140.
Nicholas Company first reported a position in MDT in Q3 2016 and has held it in 40 quarters since. The position peaked at $70.2M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Nicholas Company held 85,735 shares of Medtronic worth $6.71M as of Q2 2026.
- Nicholas Company bought 135 Medtronic shares in Q2 2026, an estimated $10.9K.
- Medtronic made up 0.12% of Nicholas Company's portfolio in Q2 2026, its #140 holding.
- Nicholas Company first reported a position in Medtronic in Q3 2016 and has held it in 40 quarters since.
- Nicholas Company's Medtronic position peaked at $70.2M in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.